Implications PCSK9 Outcome Trials: Should LDL-c targets in high-risk individuals be maintained or further lowered? - PACE-CME

Implications PCSK Outcome Trials Should LDLc targets in highrisk individuals be maintained or further lowered

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Troponin is an independent predictor of CV events at non-cardiac surgery
Troponin is an independent predictor of CV events at non-cardiac surgery
ACC.17
Troponin is an independent predictor of CV events at non-cardiac surgery
- Dr. P.J. Devereaux
LDL lowering for CVD prevention: From hypothesis to axiom
LDL lowering for CVD prevention: From hypothesis to axiom
ACC.17
LDL lowering for CVD prevention: From hypothesis to axiom
- Prof. John JP Kastelein
PCSK9 outcome trials: The results put into perspective of other clinical developments
PCSK9 outcome trials: The results put into perspective of other clinical developments
ACC.17
PCSK9 outcome trials: The results put into perspective of other clinical developments
- Prof. Peter Sever
Initiating digoxin in AF patients associated with early hazard of sudden death
Initiating digoxin in AF patients associated with early hazard of sudden death
ACC.17
Initiating digoxin in AF patients associated with early hazard of sudden death
- Dr. Renato Lopes